HK Stock Market Move | E&P GLOBAL(01142) plunged more than 50%, dropping over 70% within the month, previously mentioned by the Hong Kong Securities and Futures Commission for high concentration of shareholding.
Energy and Energy Global (01142) plunged in the afternoon, with the stock price dropping more than 50% at one point, and the cumulative decline for the month has exceeded 70%. As of the time of writing, it had fallen by 45.79%, closing at 1.16 Hong Kong dollars with a trading volume of 33.2445 million Hong Kong dollars.
E&P GLOBAL (01142) plunged in the afternoon, with the stock price dropping over 50% at one point, and the cumulative decline for the month has exceeded 70%. As of press time, it fell by 45.79%, closing at 1.16 Hong Kong dollars with a turnover of 33.2445 million Hong Kong dollars.
On the news front, in August of this year, the Hong Kong Securities and Futures Commission mentioned that E&P GLOBAL's equity is highly concentrated, with only 69.1143 million shares (1.01% of the issued share capital) held by other shareholders. The company then issued a statement confirming that at least 25% of the issued shares are held by the public as of July 31, 2025 and the date of this announcement, and the company has maintained a sufficient public shareholding level as required by listing rules. In addition, the company announced in early October that the mining license of its subsidiary in Russia has been revoked, and they plan to further appeal.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276): Injection of \(derived\) single-antibody \(drug\) approved to conduct clinical trials.

Northbound funds | Northbound trading volume reached a net buying of 5.345 billion yuan, with Europe and America adding sanctions on Russian oil. Northbound trading also increased its position in CNOOC (00883) by nearly 1 billion Hong Kong dollars.

YAN PALACE (01497) spent 810,000 Hong Kong dollars to repurchase 100,000 shares on October 23rd.
Jiangsu Hengrui Pharmaceuticals (01276): Injection of \(derived\) single-antibody \(drug\) approved to conduct clinical trials.

Northbound funds | Northbound trading volume reached a net buying of 5.345 billion yuan, with Europe and America adding sanctions on Russian oil. Northbound trading also increased its position in CNOOC (00883) by nearly 1 billion Hong Kong dollars.

YAN PALACE (01497) spent 810,000 Hong Kong dollars to repurchase 100,000 shares on October 23rd.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025